Publication | Closed Access

Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling

InflammationBone Morphogenic ProteinImmunologyOsteoarthritisBone MetabolismVivo ModelMapk SignallingOsteoporosisMedicineCell BiologyCell SignalingOrthopaedic SurgeryOxidative Stress